Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › vadadustat

vadadustat

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of vadadustat

11 trials tracked of vadadustat: 6 in phase 3 or 4 and 6 with published results. The most-cited published study has 238 citations.

11Trials tracked
6Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 3 6 Phase 2 5
  1. Phase 3 Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease Completed · 238 cited
  2. Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Completed · 237 cited
  3. Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) Completed · 195 cited
  4. Phase 3 Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) Completed · 195 cited
  5. Phase 3 Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs) Completed · 49 cited
  6. Phase 3 Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects Completed · 9 cited
Show 5 more trials
  1. Phase 2 Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Completed
  2. Phase 2 Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) Completed
  3. Phase 2 Study to Assess the Safety and Pharmacokinetics of AKB-6548 in Participants With Chronic Kidney Disease (CKD), Stages 3 and 4 Completed
  4. Phase 2 Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Completed
  5. Phase 2 Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Vafseo (vadadustat) for Anemia Due to Chronic Kidney Disease in Adults on Dialysis
Nephrology FDA Approval
FDA Approves Vafseo (vadadustat) for Anemia Due to Chronic Kidney Disease in Adults on Dialysis FDA approves a new oral pill for anemia in adults with chronic kidney disease on dialysis
The FDA has approved Vafseo (vadadustat) for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysi…
FDA approves a new oral pill for anemia in adults with chronic kidney disease on dialysis, offering a non-transfusion option for those treat…
FDA Apr 3, 2026